Company Filing History:
4 out of 541 
4 out of 37 Years Active: 2021-2025
Title: The Innovative Contributions of Meghan Pennini
Introduction
Meghan Pennini is a notable inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific pathogens. With a total of 4 patents to her name, her work has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
Among her latest patents, Meghan has developed innovative binding proteins, including Anti-O2 antibodies and Anti-O1 antibodies. The Anti-O2 antibodies specifically bind to O2 and induce opsonophagocytic killing of Klebsiella pneumoniae, providing a method to reduce or treat infections in subjects. Similarly, the Anti-O1 antibodies target O1 and also facilitate the killing of pathogens, offering therapeutic options for infection prevention.
Career Highlights
Throughout her career, Meghan has worked with prominent companies in the biotechnology sector, including MedImmune Limited and Humabs Biomed SA. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in antibody development.
Collaborations
Meghan has collaborated with esteemed colleagues such as Qun Wang and Charles K. Stover. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Meghan Pennini's contributions to the field of biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments and infection control.